1. Aide
    1. Espace Client
    2. Connexion
  1. Aide
    1. Espace Client
    2. Connexion
Espace Membre Boursorama

Erreur d'authentification

Vous êtes authentifié. Nous chargeons votre espace membre.

Mot de passe oublié ?

Nouveau sur Boursorama ? Devenez membre

Identifiant/Mot de passe oublié
Si vous êtes Membre de la Communauté Boursorama, veuillez indiquer l'adresse email que vous avez fournie lors de votre enregistrement pour recevoir votre identifiant et/ou ré-initialiser votre mot de passe :

Nouveau sur Boursorama ? Devenez membre


NATUREX : Extraordinary General Meeting on 12 November 2015
Actusnews22/10/2015 à 08:00

Avignon, 22nd October 2015 - Naturex, the global leader in specialty plant-based natural ingredients, informs its shareholders of an Extraordinary General Meeting focusing on a resolution about the allocation of free shares following the new provisions of Act No. 2015-990 of August 6, 2015 for growth, activity and equal economic opportunities, law called "Macron".

This Extraordinary General Meeting will be held on:

Thursday 12 November 2015, at 6 pm
31 Avenue Pierre 1er de Serbie
75016 Paris

The shareholders are invited to consult on the Company's website (www.naturex.com) the preliminary notice to the Extraordinary General Meeting that has been published on 2nd October 2015, in the Official List n°118 (BALO - Bulletin des Annonces Légales Obligatoires) and that comprises the agenda, the draft resolutions and details on attending and voting.

In addition, other documents and information related to this Extraordinary General Meeting (Report of the Board of Directors, report of the Statutory Auditors, voting form ...) are also posted online and made available at Naturex's head office, in compliance with the French legal and regulatory provisions.

You can receive all financial information of Naturex free of charge by signing up at: www.naturex.com

  • Financial schedule
    - Q3 2015 sales 4 November 2015
    - Q3 2015 results 30 November 2015
  • Upcoming events
    - Extraordynary General Meeting (Paris) 12 November 2015
    - ACTIONARIA tradeshow (Paris) 20 and 21 November 2015

Naturex has been listed since October 1996 on Euronext in Paris, Segment B

  Total number of shares comprising the share capital: 9,221,113 (September 2015)
ISIN FR0000054694

Naturex is a component of the CACT, Enternext CAC PEA-PME 150, CAC Small & Mid, CAC Small, Gaïa Index.
Naturex is eligible for the "long only" Deferred Settlement Service (SRD) and French equity plans (PEA and PEA-PME).
Naturex established a Sponsored Level 1 American Depositary Receipt (ADR) program in the United States. Under this facility, Naturex's ADRs are traded over-the-counter in the United States under the symbol NTUXY.


About Naturex

Naturex is the global leader in speciality plant-based natural ingredients. The Group is organised around three strategic markets (Food & Beverage, Nutrition & Health and Personal Care) and produces and markets speciality plant-based ingredients for the food, nutraceutical, pharmaceutical and cosmetic industries.

Naturex's head office is based in Avignon. The company employs 1,700 people with 8 sourcing offices located throughout the world and high-performance manufacturing operations across 15 sites in Europe, Morocco, the United States, Brazil, Australia and India. It also has a global commercial presence through a dedicated network of sales offices in more than 20 countries.

  • Contacts
Carole Alexandre
Investor Relations
Tel.: +33 (0)4 90 23 78 28
Anne Catherine Bonjour
Actus Finance Press Relations
Tel.: +33 (0)1 53 67 36 93

Information réglementée
Communiqués de mise à disposition de documents :
- Modalités de mise à disposition des documents préparatoires à l'AG
Full and original press release in PDF:

Valeurs associées

Euronext Paris 0.00%

0 commentaire

Vous devez être membre pour ajouter un commentaire.
Vous êtes déjà membre ? Connectez-vous
Pas encore membre ? Devenez membre gratuitement

Signaler le commentaire


Mes listes

Une erreur est survenue pendant le chargement de la liste




Les Risques en Bourse